Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation.
Bang K, Casadei-Gardini A, Yoo C, Iavarone M, Ryu MH, Park SR, Kim HD, Yoon YI, Jung DH, Park GC, Ahn CS, Moon DB, Hwang S, Kim KH, Song GW, Mazzarelli C, Alimenti E, Chan SL, De Giorgio M, Ryoo BY, Lee SG.
Bang K, et al. Among authors: ahn cs.
Cancer Med. 2023 Feb;12(3):2572-2579. doi: 10.1002/cam4.5123. Epub 2022 Aug 5.
Cancer Med. 2023.
PMID: 36812124
Free PMC article.